Adverum Biotechnologies I... (ADVM)
NASDAQ: ADVM
· Real-Time Price · USD
2.21
-0.02 (-0.90%)
At close: May 23, 2025, 3:59 PM
2.21
0.00%
After-hours: May 23, 2025, 04:04 PM EDT
Adverum Biotechnologies Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 1M |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 19.47M | 13.79M | 9.78M | 11.03M | 11.73M | 9.87M | 13.79M | 12.47M | 12.78M | 11.74M | 17.19M | 13.76M | 15.17M | 11.89M | 14.45M | 21.93M | 16.16M | 13.65M | 11.35M | 10.6M | 9.04M | 8.28M | 7.39M | 7.13M | 5.58M | 5.19M | 4.83M | 9.18M | 5.37M | 4.04M | 4.76M | 4.06M | 7.99M | 4.78M | 6.15M | 5.11M | 8.32M | 5.37M | 7.63M | 4.96M | 4.14M |
| Selling, General, and Administrative Revenue Growth | +41.23% | +40.96% | -11.31% | -5.99% | +18.85% | -28.41% | +10.61% | -2.46% | +8.85% | -31.69% | +24.91% | -9.29% | +27.52% | -17.70% | -34.09% | +35.68% | +18.39% | +20.27% | +7.11% | +17.23% | +9.19% | +12.04% | +3.60% | +27.91% | +7.50% | +7.48% | -47.42% | +70.99% | +32.81% | -15.12% | +17.18% | -49.13% | +67.24% | -22.27% | +20.18% | -38.52% | +54.78% | -29.58% | +53.88% | +19.70% | n/a |
| Research and Development Revenue | 28.75M | 24.09M | 20.44M | 17.1M | 15.41M | 15.08M | 20.74M | 20.6M | 21.06M | 22.2M | 23.85M | 30.27M | 22.96M | 22.52M | 24.07M | 22.61M | 19.98M | 22.73M | 16.65M | 19.18M | 14.75M | 11.37M | 9.94M | 8.97M | 10.13M | 11.64M | 14.48M | 11.22M | 12.79M | 12.01M | 10.27M | 8.49M | 9.06M | 7.9M | 8.36M | 7.96M | 7.46M | 7.19M | 7.52M | 5.13M | 5.62M |
| Research and Development Revenue Growth | +19.31% | +17.89% | +19.55% | +10.95% | +2.20% | -27.30% | +0.68% | -2.18% | -5.14% | -6.92% | -21.20% | +31.79% | +1.95% | -6.42% | +6.46% | +13.15% | -12.09% | +36.48% | -13.16% | +30.00% | +29.69% | +14.38% | +10.86% | -11.46% | -12.98% | -19.60% | +29.09% | -12.33% | +6.49% | +16.96% | +20.96% | -6.28% | +14.73% | -5.55% | +5.12% | +6.71% | +3.66% | -4.40% | +46.76% | -8.81% | n/a |